prostate hyperplasia, prostate cardinoma
Regulatory status: IVD, FDA Class I
8244-C010: RTU, 10 capsules; 1 pack
8244-M250: RTU, 250 tests, 1 cartridge; 1 unit
Prostate Specific Antigen (PSA) is expressed in different types of prostate carcinoma, both primary and metastatic. It is found in approximately 99% of prostatic adenocarcinoma cases, with high grade carcinomas often displaying weaker expression.
Strong granular cytoplasmic expression is seen for PSA in this prostatic adenocarcinoma.
This kidney specimen shows no reactivity for PSA.